𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

✍ Scribed by L. Lindström; K. M. Boberg; O. Wikman; I. Friis-Liby; R. Hultcrantz; H. Prytz; H. Sandberg-Gertzén; P. Sangfelt; A. Rydning; G. Folvik; M. Gangsøy-Kristiansen; Å. Danielsson; Annika Bergquist

Book ID
108606580
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
249 KB
Volume
35
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose ursodeoxycholic acid for the t
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve